PranaX

Pioneers in regenerative biomedical products that transform how people age.

01/29/2026

We’re excited to share that PranaX has closed an oversubscribed $17M Series A round, led by family offices and strategic investors with deep expertise in biotechnology and regenerative medicine. The funding supports PranaX’s next phase of growth as the exosome sector continues to gain momentum.

Read more here: https://na2.hubs.ly/H03ldn20

12/22/2025

As the year comes to an end, we want to thank our partners, customers, collaborators, and dedicated team for an unforgettable year. We’re excited for the year ahead, with many new developments to share.

Best wishes for a joyful holiday season and a successful New Year from all of us at PranaX.

12/02/2025

In 2025, there’s a good chance you’ve heard the term “exosomes.” While the interest around them continues to grow, it’s important to remember that exosomes are not just a trend and that they’re a well-established area of scientific study.

Exosomes are small extracellular vesicles (30–150 nm) secreted by most cell types, playing a critical role in intercellular communication. They carry bioactive molecules, including proteins, lipids, and nucleic acids (e.g., mRNA, miRNA), which influence physiological and pathological processes of recipient cells.

Did you know that the human body has ~37 trillion cells, and many secrete hundreds to thousands of exosomes per day?

Address

6420 Levit Green Boulevard Suite 220
Houston, TX
77021

Website

https://pranax.com/

Alerts

Be the first to know and let us send you an email when PranaX posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Engineering Company in Houston?